Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05464927 · ClinicalTrials.gov registry record
Visualizing Vascular Mechanisms of Lipedema
A clinical trial of Lipedema, sponsored by University of Virginia.
- Active
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT05464927: Active study of Lipedema, sponsored by University of Virginia.
NCT05464927 is a study of Lipedema that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 110 participants, below the 190-participant average among 4 other Lipedema trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05464927, a study of Lipedema, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This work will address clinical unmet needs for patients with lipedema using advanced magnetic resonance imaging (MRI) methods, in sequence with portable clinical tools, by testing fundamental hypotheses regarding potential screening methods, lymphatic therapy, and vascular dysfunction in patients with lipedema.
Primary Outcome
Tissue sodium content (mmol/L) quantified by sodium MRI
Conditions Studied
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2027-01-01 |
What the registry record for NCT05464927 still lists
NCT05464927 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 190-participant average among 4 other Lipedema trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Lipedema appearing as the primary indexed condition, and to 0 interventions.
NCT05464927 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05464927 about?
NCT05464927 is a clinical study titled "Visualizing Vascular Mechanisms of Lipedema". This work will address clinical unmet needs for patients with lipedema using advanced magnetic resonance imaging (MRI) methods, in sequence with portable clinical tools, by testing fundamental hypotheses regarding potential screening methods, lymphatic therapy, and vascular dysfunction in patients w...
What is the current status of trial NCT05464927?
This trial is currently active not recruiting. The enrollment target is 110 participants. The study started on 2021-09-01. Estimated completion is 2027-01-01.
What conditions does trial NCT05464927 study?
This clinical trial studies the following conditions: Lipedema.
Who is sponsoring clinical trial NCT05464927?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05464927 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lipedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI